Dogecoin and ethereum hit new record highs as crypto market surges

Globe Newswire

Global IVD Market Report 2021 with COVID-19 Impacts (Q3 2020 to Q1 2021)

Dublin, May 04, 2021 (GLOBE NEWSWIRE) — The “2021 IVD Market Update and COVID-19 Impact” report has been added to ResearchAndMarkets.com’s offering. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from the report’s analysts to reflect the latest information. Key Questions Answered: What is the Size of the IVD Market in 2021?What Impact has COVID-19 Had on IVD Markets?What Major Trends are Affecting the Market in 2021? As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical ChemistryImmunoassays- non isotopicInfectious diseaseOther immunosBlood bank screeningDrugs of AbuseDiabetes HbA1c – labHematology – Core LabMicrobiology (ID/AST)Microbiology (molecular)Microbiology – Mass SpectrometryRadioimmunoassaysCoagulation (PT/INR)Coagulation, molecularHistology/cytologyHPV, molecularNucleic acid assaysBlood grouping/typingBlood bank molecularNAT Blood ScreensCirculating tumor cellsPOC, OTC diabetesPOC, OTC otherPOC, professional/hospital;COVID 19 Complete market figures and forecasts will be part of the Worldwide report in August. How is COVID-19 Impacting the Market in 2021 This report does detail the effects of COVID-19 including the following: Effect of COVID-19 on Market SegmentsIVD Market excluding and with COVID-19, 2020IVD Market Distribution by SegmentGlobal In Vitro Diagnostic Market – YoY Growth 2019-2020Global In Vitro Diagnostic Market – YoY Growth 2019-2020IVD Segment Performance, Q1 2020 – Q4 2020IVD Segment Performance, Total Market Value, 2020 Also included in this report: Product Trends and DevelopmentsCOVID-19 Developments Sept. 2020 to Feb 2021Select IVD Market Participant DevelopmentsCompetitive Leader Updates Key Topics Covered: ONE: WORLDWIDE IVD MARKET – 2020 UPDATE COVID 19 IVD MARKET HIGHLIGHTS AND EFFECTS OF COVID-19 Effect of COVID-19 on Market Segments TWO: PRODUCT TRENDS AND NEW DEVELOPMENTS NEW CORE IVD PRODUCT LAUNCHES AND DEVELOPMENTS Clinical ChemistryHematologyOncologyCoagulationImmunoassayMicrobiologyHistologyMolecular SpecialtiesPOCMass Spectrometry COVID-19 DEVELOPMENTS – SEPTEMBER 2020 – FEBRUARY 2021AntigenSerologyMolecular THREE: SELECTED IVD MARKET PARTICIPANT DEVELOPMENTS SELECTED COMPETITIVE LEADER UPDATES IVD Segment Growth by Leading Competitors, Change in Sales 2019-2020Changes in Market Distribution for IVD Sales, 2019-2020 – Roche Maintains Lead, Abbott Closing Gap AbbottAidian OyBecton Dickinson and CoBiomerieux SADanaherHologic, Inc.IlluminaOrtho Clinical DiagnosticsPerkin ElmerQuidel CorporationRoche DiagnosticThermo Fisher Scientific FOUR: NEW OPPORTUNITIES Telehealth and Remote Patient MonitoringExpanding Options in ReimbursementPOC For more information about this report visit https://www.researchandmarkets.com/r/9mobgz CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900